CCDC116 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of CCDC116, a coiled-coil domain-containing protein. Proteins with coiled-coil domains, like CCDC116, are involved in mediating protein-protein interactions and are critical in various cellular functions such as scaffolding, intracellular transport, and structural organization. CCDC116 itself is thought to play a role in these processes by acting as a molecular scaffold that facilitates the formation of protein complexes, thereby influencing key pathways in cellular signaling and structural integrity. Inhibiting CCDC116 can disrupt these interactions and modulate cellular behavior by affecting the assembly of protein networks and complexes within the cell.
The mechanism by which CCDC116 inhibitors function often involves direct interaction with the coiled-coil domain of the protein, preventing it from binding to other proteins or forming stable complexes. This interference can lead to the breakdown of the protein structures and pathways in which CCDC116 is involved, impacting cellular processes such as cytoskeletal organization, vesicle trafficking, and intracellular signaling. Researchers utilize CCDC116 inhibitors as tools to explore the functional roles of coiled-coil domain-containing proteins in cellular processes. By inhibiting CCDC116, scientists can gain insights into how protein scaffolding and complex assembly are regulated in cells and how disruptions in these processes can affect cell structure and function. This research helps to uncover the broader roles of coiled-coil proteins in maintaining cellular homeostasis and the organization of intracellular networks.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A inhibits histone deacetylases, leading to altered chromatin structure and potentially reducing gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine incorporates into DNA and inhibits DNA methyltransferases, potentially affecting gene expression patterns. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D intercalates into DNA, inhibiting RNA polymerase and thus reducing mRNA synthesis for many genes. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin binds to and inhibits RNA polymerase II, preventing mRNA transcription of most genes. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG108 is a DNA methyltransferase inhibitor, which may lead to hypomethylation and altered gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Sirolimus binds to mTOR and inhibits its pathway, which can lead to reduced protein synthesis including various genes. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine can alkalinize lysosomes and inhibit DNA and RNA synthesis in certain conditions. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Decitabine is incorporated into DNA where it inhibits methylation, potentially affecting gene expression. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Flavopiridol inhibits cyclin-dependent kinases, which can result in the suppression of gene transcription. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
JQ1 inhibits the BET family of bromodomain proteins, affecting transcriptional regulation of several genes. |